Language Barriers Are Most Underestimated Risk in Healthcare

A deep analysis of why hospitals still struggle to close the language gap, and what the shift from compliance to clinical outcomes actually requires.

Healthworks Collective is committed to exploring overlooked risks in healthcare, with a focus on how language barriers continue to threaten patient safety in 2026. Something that many providers underestimate is how often miscommunication leads to delayed diagnoses, medication errors, and reduced trust between patients and care teams.

Ana Gonzalez-Barrera, Liz Hamel, Samantha Artiga, and Marley Presiado of Kaiser Family Foundation report that in the U.S., 26 million people have limited English proficiency, representing about 8% of people ages 5 and older. There are clear signs that this large population faces consistent gaps in care quality due to communication challenges, and you can see how even small misunderstandings can escalate into serious clinical risks. Keep reading to learn more.

Why Language Barriers Continue to Put Patients at Risk

A study by Hilal Al Shamsi, Abdullah G Almutairi, Sulaiman Al Mashrafi and Talib Al Kalbani published in Oman Medical Journal found that 37% of physicians reported they felt that patients hide some information because of the language barrier. Another thing clinicians face is the inability to confirm whether patients fully understand instructions, and it is often assumed that nodding or brief responses indicate comprehension when they do not. You may not realize how often critical details are lost when patients feel uncomfortable or unable to express symptoms clearly. Something that makes this worse is the lack of consistent interpreter access across many care settings.

Nearly 30 million people in the United States have limited English proficiency. That number is not new. What is new is the growing body of evidence showing that language barriers do not simply inconvenience patients. They actively endanger them. Research published in ScienceDirect confirms that individuals with limited English proficiency experience higher uninsured rates, lower use of preventive care, and measurably poorer health outcomes than their English-proficient counterparts.

For professionals tracking global healthcare policy and patient access, these disparities represent more than a social determinant of health. They represent a systemic failure in how care is designed, delivered, and documented. The question is no longer whether language barriers harm patients. It is why the healthcare industry continues to treat translation as an afterthought rather than a clinical imperative.

The Regulatory Shift That Changes the Conversation

In January 2026, The Joint Commission formally reclassified language access from a quality initiative to a patient safety requirement under its National Performance Goals for the Hospital Program. This is a significant shift in how regulators view multilingual communication. It places language access on the same operational tier as infection prevention and medication safety.

The evidence behind this reclassification is substantial. A 2025 scoping review published in the Joint Commission Journal examined 22 studies comparing patient safety event risk among those who experience language barriers with those who do not. The findings consistently pointed in one direction: patients facing language barriers are at greater risk of adverse events, longer hospital stays, and delayed treatment. Organizations pursuing health equity accreditation will increasingly need to demonstrate not just interpreter availability, but measurable language access outcomes tied to clinical quality.

Why Interpreter Services Alone Fall Short

Most hospitals rely on interpreter services to address language barriers. These services are essential, and they save lives. But they also have structural limitations that the industry has been slow to acknowledge. Interpreter availability is inconsistent outside of business hours. Wait times in emergency departments can stretch beyond what is clinically acceptable. And the scope of interpreter services rarely extends to the written materials that patients take home: discharge instructions, medication guides, consent forms, and follow-up care plans.

The distinction matters because written medical information carries its own patient safety weight. A discharge instruction that tells a patient to take medication “twice daily” in English has no clinical value for a patient who reads only Haitian Creole or Tagalog. The role of professional medical translators in bridging this gap has been documented for years, yet the operational infrastructure to support consistent written translation in clinical workflows remains rare.

The Digital Health Gap Nobody Talks About

The rise of patient portals, telehealth platforms, and digital intake forms has created a second layer of language exclusion. A 2025 University of Michigan study published in JAMA Network Open found that 29% of U.S. hospitals do not offer their patient portal login page in any language other than English. Only 11% offered access in English, Spanish, and a third language. This means the digital tools that hospitals have invested millions of dollars building are functionally invisible to a significant share of their patient population.

This is one of the IT challenges healthcare organizations face that receives surprisingly little attention in digital transformation conversations. The assumption appears to be that if a hospital offers in-person interpreter services, the digital experience does not need the same level of language support. But as more clinical communication moves online, that assumption becomes a patient safety liability.

What Regulated Industries Already Know About Translation Quality

Part of the reason language access stalls at the operational level is that hospitals frame translation as a single task rather than a workflow. Translate the document. Check the box. Move on. But clinical translation is not a single task. It involves terminology that shifts across specialties, regulatory language that varies by state and payer, and cultural context that affects how patients interpret instructions.

A systematic review in the Oman Medical Journal found that when hospitals deployed digital translation tools alongside interpreter services, satisfaction rates for both medical providers and patients rose to 92%. The combination mattered more than either approach in isolation. This finding suggests that the most effective language access strategies are hybrid ones that pair human expertise with technology.

Healthcare is not the first industry to confront this challenge. Legal firms handling cross-border arbitration, financial institutions translating regulatory filings, and pharmaceutical companies managing multilingual clinical trial documentation have all wrestled with the same question: how do you translate high-stakes content at speed without sacrificing accuracy? The answer that has emerged across these sectors is consistent. Neither fully automated translation nor fully manual processes are enough on their own. The organizations that get it right are the ones that treat translation as a structured, multi-step workflow with built-in verification at every stage.

Building a Translation Workflow That Matches the Clinical Stakes

A hybrid translation workflow combines machine translation output with human post-editing by qualified linguists who hold subject-matter expertise. In a clinical setting, this means a consent form or discharge summary is first processed through AI translation for speed, then reviewed by a translator who understands the medical terminology, the target language’s idiomatic norms, and the regulatory requirements specific to that document type.

Translation company Tomedes has operationalized this model across legal, medical, and financial verticals, pairing AI-assisted translation with native-speaking translators who carry domain credentials. Their process is backed by ISO-certified quality controls, which means every translated document passes through a standardized review chain before delivery. For healthcare organizations looking to build or benchmark their own internal translation standards, this type of structured, audit-ready methodology offers a useful reference point.

From Compliance Checkbox to Clinical Outcome

The Nimdzi “What Localization Buyers REALLY Want 2025” report found that one of the biggest challenges organizations face when adopting language technology is the disconnect between executive mandates and operational reality. Leadership sees language access as a compliance requirement. Operational teams see it as a resource constraint. Neither framing puts patients first.

That perspective reflects a broader principle gaining traction among organizations that serve regulated industries: measuring translation success not by volume or turnaround, but by whether the end reader can act on the information safely. Reframing translation as a clinical outcome rather than an administrative task changes the calculus. It shifts budget conversations from cost-per-word to cost-per-adverse-event-avoided. It changes vendor selection criteria from turnaround time alone to accuracy, subject-matter expertise, and regulatory compliance. And it positions language access where The Joint Commission now says it belongs: alongside the other systems that keep patients safe.

The Path Forward

Language barriers in healthcare are not a new problem. But the regulatory environment, the research base, and the available technology have all shifted enough that the old approaches no longer hold. Interpreter services remain critical. But they are not sufficient on their own, especially as care delivery moves increasingly into digital channels that require written multilingual content at scale.

For healthcare administrators, compliance officers, and patient safety leaders, the opportunity in 2026 is to move language access from a reactive accommodation into a proactive system. That means investing in translation workflows that are structured, verifiable, and tied to measurable patient outcomes. It means recognizing that the gap between verbal interpretation and written translation is not a minor detail. It is a patient safety exposure that the industry can no longer afford to ignore.